Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-05

Clinical Trial Update: QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)

View source ↗

Summary

This document reports a completed clinical trial evaluating quality of life in distal ulcerative colitis patients treated with mesalamine (Pentasa), with update…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PENTASA (MESALAMINE)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Distal Ulcerative Colitis | Status: COMPLETED